Company intelligence / Profile preview

Analgesic Solutions

Wayland, Massachusetts, United Stateswcgclinical.com ↗

Ownership: Private
Employees: ~7
Development stage: Phase 3

Overview

Provides consulting and technology solutions to reduce risk and improve accuracy in clinical trials focused on pain. Has supported hundreds of projects, including Phase 3 studies such as those involving Xtampza ER for chronic low back pain. No proprietary drug assets; specializes in trial design, regulatory support, and patient symptom reporting technologies.

Therapeutic areas: NeurologyRheumatology
Industry: Contract Research Organization

Partnerships

Ongoing collaborations with regulatory authorities such as the FDAPartnerships are primarily with pharmaceutical sponsors running clinical trials

Beyond the preview

Go deeper on Analgesic Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Analgesic Solutions.

Explore the full profile